Diagnostics, Radionucleotides, Contract Manufacturing

SpectronRx specializes in the development and production of radiopharmaceuticals, offering comprehensive services that encompass contract development and manufacturing organization (CDMO) and radiopharmaceutical development and manufacturing organization (RDMO) capabilities. The company excels in regulatory assistance, guiding clients through the complexities of achieving full FDA approval. Their expertise extends to the labeling of monoclonal antibodies (mAb), nanobodies, and peptides using a variety of isotopes, supported by a team of professionals with advanced degrees in radiochemistry. SpectronRx is also recognized for its robust logistics capabilities, ensuring timely and temperature-controlled delivery of products through a well-established global supplier network.

In addition to their core services, SpectronRx provides extensive support in isotope procurement and management, leveraging their knowledge of a wide range of isotopes, including Ac-225, Lu-177, and F-18. The company operates multiple CDMO facilities equipped with cleanrooms and advanced quality control analytical support, enabling them to meet both domestic and international regulatory requirements. Their strategic approach to drug development encompasses everything from early-stage therapeutic and diagnostic services to commercialization, making them a valuable partner for clients navigating the complexities of the drug lifecycle.

United States

SPECTRONRx provides therapeutic and diagnostic Isotopes for clinical and research use. They specialize in providing you flexible and efficient Contract Manufacturing and Contract Research services.COVID-19: EUA (O5/2020) Hymon SARS-CoV-2 Test Kit.

SpectronRx

Company Details